JP2025163031A5 - - Google Patents
Info
- Publication number
- JP2025163031A5 JP2025163031A5 JP2025113783A JP2025113783A JP2025163031A5 JP 2025163031 A5 JP2025163031 A5 JP 2025163031A5 JP 2025113783 A JP2025113783 A JP 2025113783A JP 2025113783 A JP2025113783 A JP 2025113783A JP 2025163031 A5 JP2025163031 A5 JP 2025163031A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- liposome
- amino acid
- acid sequence
- helper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762577157P | 2017-10-25 | 2017-10-25 | |
| US62/577,157 | 2017-10-25 | ||
| PCT/US2018/057286 WO2019084118A2 (en) | 2017-10-25 | 2018-10-24 | PHOSPHORYLATED TUBE PEPTIDE COMPOSITIONS AND USES THEREOF |
| JP2020523284A JP7550643B2 (ja) | 2017-10-25 | 2018-10-24 | リン酸化タウペプチドの組成物およびその使用 |
| JP2023018374A JP7793562B2 (ja) | 2017-10-25 | 2023-02-09 | リン酸化タウペプチドの組成物およびその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023018374A Division JP7793562B2 (ja) | 2017-10-25 | 2023-02-09 | リン酸化タウペプチドの組成物およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025163031A JP2025163031A (ja) | 2025-10-28 |
| JP2025163031A5 true JP2025163031A5 (cg-RX-API-DMAC7.html) | 2026-02-24 |
Family
ID=64362628
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020523284A Active JP7550643B2 (ja) | 2017-10-25 | 2018-10-24 | リン酸化タウペプチドの組成物およびその使用 |
| JP2023018374A Active JP7793562B2 (ja) | 2017-10-25 | 2023-02-09 | リン酸化タウペプチドの組成物およびその使用 |
| JP2025113783A Pending JP2025163031A (ja) | 2017-10-25 | 2025-07-04 | リン酸化タウペプチドの組成物およびその使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020523284A Active JP7550643B2 (ja) | 2017-10-25 | 2018-10-24 | リン酸化タウペプチドの組成物およびその使用 |
| JP2023018374A Active JP7793562B2 (ja) | 2017-10-25 | 2023-02-09 | リン酸化タウペプチドの組成物およびその使用 |
Country Status (25)
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202333768A (zh) | 2017-10-25 | 2023-09-01 | 美商健生醫藥公司 | Tau胜肽之組成物及其用途 |
| WO2020123492A1 (en) * | 2018-12-10 | 2020-06-18 | New York University | Monoclonal antibodies targeting c-terminal region of phosphorylated tau |
| SG11202108312PA (en) | 2019-02-08 | 2021-08-30 | Ac Immune Sa | Method of safe administration of phosphorylated tau peptide vaccine |
| MX2021012994A (es) * | 2019-04-24 | 2022-03-04 | Janssen Pharmaceuticals Inc | Administracion heterologa de vacunas tau. |
| CN114341364B (zh) * | 2019-07-08 | 2025-07-18 | 阿尔兹卡生物科学公司 | Tau病理靶向配体 |
| CN114728169A (zh) * | 2019-09-23 | 2022-07-08 | 麦考瑞大学 | tau蛋白病的治疗 |
| US11744874B2 (en) | 2019-12-20 | 2023-09-05 | Nammi Therapeutics, Inc. | Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof |
| CN115968291A (zh) * | 2020-04-22 | 2023-04-14 | 南湖制药公司 | 聚乙二醇化干扰素tau及其组合物和方法 |
| CN116472055A (zh) | 2020-08-07 | 2023-07-21 | 欧萨尔普罗席纳有限公司 | 治疗阿尔兹海默氏病的多表位疫苗 |
| WO2022054795A1 (ja) * | 2020-09-08 | 2022-03-17 | 国立大学法人大阪大学 | リン酸化タウタンパク質を標的とする免疫原性組成物 |
| CA3192429A1 (en) * | 2020-09-17 | 2022-03-24 | Robin Barbour | Alpha-synuclein vaccine for the treatment of synucleinopathies |
| KR20240042508A (ko) * | 2021-08-12 | 2024-04-02 | 얀센 파마슈티칼즈, 인코포레이티드 | 지속적인 면역 반응을 유도하기 위한 인산화 타우 펩티드를 함유하는 리포솜 |
| EP4408864A4 (en) * | 2021-09-29 | 2025-09-03 | Janssen Pharmaceuticals Inc | METHOD FOR SAFE ADMINISTRATION OF A TAU PHOSPHOPEPTIDE CONJUGATE |
| IL314865A (en) * | 2022-02-09 | 2024-10-01 | Ac Immune Sa | Anti-alpha-synuclein therapeutic vaccines |
| CA3261968A1 (en) * | 2022-07-14 | 2024-01-18 | Vaxxinity, Inc. | IMMUNOGENEOUS TAU PEPTIDE CONSTRUCTIONS |
| AU2024367338A1 (en) * | 2023-10-24 | 2026-04-30 | Ac Immune Sa | Method of treating preclinicial alzheimer's disease |
| WO2025109524A1 (en) | 2023-11-22 | 2025-05-30 | Ac Immune Sa | Assays and methods for assessing vaccine preparations |
| KR102988842B1 (ko) | 2024-10-22 | 2026-07-09 | 주식회사 엘지에너지솔루션 | 리튬 이차 전지용 음극, 리튬 이차 전지, 전지 모듈 및 전지 팩 |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811310A (en) | 1986-09-30 | 1998-09-22 | Albert Einstein College Of Medicine Of Yeshiva Univ. | The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease |
| WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| US7408027B1 (en) | 1991-12-06 | 2008-08-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften | Tools for the diagnosis and treatment of Alzheimer's disease |
| AU690092B2 (en) | 1992-12-14 | 1998-04-23 | N.V. Innogenetics S.A. | Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| US7427392B1 (en) | 1994-11-14 | 2008-09-23 | Elan Pharmaceuticals, Inc. | Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau |
| WO1997034145A1 (fr) | 1996-03-13 | 1997-09-18 | Mitsubishi Chemical Corporation | Anticorps a proteine tau antiphosphorylee et procede de detection de la maladie d'alzheimer l'utilisant |
| WO1998022120A1 (en) | 1996-11-19 | 1998-05-28 | The Wistar Institute Of Anatomy & Biology | Diagnostic and therapeutic reagents for alzheimer's disease |
| EA003739B1 (ru) | 1997-12-03 | 2003-08-28 | Байоджен, Инк. | Гидрофобно-модифицированные белки, способы их получения и их применение |
| US6314469B1 (en) | 1999-02-26 | 2001-11-06 | I-Dns.Net International Pte Ltd | Multi-language domain name service |
| AU2001273361A1 (en) | 2000-07-11 | 2002-01-21 | Molecular Geriatrics Corporation | Reagents and methods for identification of binding agents |
| GB0114719D0 (en) | 2001-06-15 | 2001-08-08 | Glaxo Group Ltd | Compound |
| AU2003203079B9 (en) | 2002-02-04 | 2009-01-15 | Oncothyreon Inc. | Immunostimulatory, covalently lipidated oligonucleotides |
| KR100994748B1 (ko) | 2002-04-19 | 2010-11-17 | 더 가버닝 카운실 오브 더 유니버시티 오브 토론토 | 알쯔하이머병의 치료를 위한 면역학적 방법 및 조성물 |
| KR20050101537A (ko) | 2002-12-24 | 2005-10-24 | 뉴로켐 (인터내셔널) 리미티드 | 베타-아밀로이드 관련 질환의 치료를 위한 치료 제제 |
| US8663650B2 (en) | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
| WO2005058137A2 (en) | 2003-12-12 | 2005-06-30 | University Of Washington | Catheterscope 3d guidance and interface system |
| US20050261475A1 (en) | 2004-02-13 | 2005-11-24 | Harvard Medical School | Solid-phase capture-release-tag methods for phosphoproteomic analyses |
| US7238788B2 (en) | 2004-02-18 | 2007-07-03 | University Of Iowa Foundation | Antibodies to phosphorylated tau, methods of making and methods of use |
| WO2006121656A2 (en) | 2005-05-05 | 2006-11-16 | Merck & Co., Inc. | Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease |
| WO2007068105A1 (en) | 2005-12-12 | 2007-06-21 | Robarts Research Institute | Method of diagnosing amyotrophic lateral sclerosis |
| CA2633399C (en) | 2005-12-12 | 2016-01-26 | Ac Immune S.A. | Therapeutic vaccine |
| EP2514824A3 (en) | 2006-03-03 | 2013-01-23 | Amorfix Life Sciences Ltd. | Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
| US8012936B2 (en) | 2006-03-29 | 2011-09-06 | New York University | Tau fragments for immunotherapy |
| US20080220449A1 (en) | 2007-02-08 | 2008-09-11 | Oligomerix, Inc. | Biomarkers and assays for Alzheimer's disease |
| KR20100115340A (ko) | 2007-10-19 | 2010-10-27 | 이무나스 파마 가부시키가이샤 | Aβ 올리고머에 특이적으로 결합하는 항체 및 그의 이용 |
| US9498522B2 (en) | 2008-08-07 | 2016-11-22 | Mercia Pharma Inc. | Immunotherapeutic compositions for the treatment of alzheimer'S disease |
| CN102365295A (zh) | 2009-01-30 | 2012-02-29 | 阿德利夫股份有限公司 | 构象动力肽 |
| US9605054B2 (en) | 2009-02-23 | 2017-03-28 | The Board Of Trustees Of The University Of Illinois | Composition and method for treating a tauopathy |
| MX2011009654A (es) | 2009-03-18 | 2011-10-12 | Ac Immune Sa | Metodo para uso terapeutico. |
| UA107571C2 (xx) | 2009-04-03 | 2015-01-26 | Фармацевтична композиція | |
| EP4218794A3 (en) | 2009-06-10 | 2023-09-13 | New York University | Immunological targeting of pathological tau proteins |
| CN102596236B (zh) | 2009-07-30 | 2015-06-24 | 辉瑞疫苗有限责任公司 | 抗原性Tau肽及其用途 |
| AU2010291933B2 (en) | 2009-09-14 | 2016-09-08 | Banyan Biomarkers, Inc. | Micro-RNA, autoantibody and protein markers for diagnosis of neuronal injury |
| KR20130103662A (ko) | 2010-04-19 | 2013-09-24 | 엔라이프 떼라퓨틱스, 에스.엘. | 올리고뉴클레오티드 분자들의 특정 뉴런 유형들로의 선택적인 전달을 위한 조성물들 및 방법 |
| WO2012020124A1 (en) | 2010-08-12 | 2012-02-16 | Ac Immune S.A. | Vaccine engineering |
| EP2632434B1 (en) * | 2010-10-26 | 2025-08-20 | AC Immune S.A. | Liposome-based construct comprising a peptide modified through hydrophobic moieties |
| GB201112056D0 (en) * | 2011-07-14 | 2011-08-31 | Univ Leuven Kath | Antibodies |
| EP3275461A1 (en) * | 2011-09-19 | 2018-01-31 | Axon Neuroscience SE | Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease field |
| CA2811188C (en) | 2011-09-23 | 2020-04-28 | Andrea Pfeifer | Vaccine therapy |
| WO2013058350A1 (ja) | 2011-10-21 | 2013-04-25 | 三菱化学株式会社 | 周期表第13族金属窒化物半導体結晶の製造方法、及び該製造方法により製造される周期表第13族金属窒化物半導体結晶 |
| EP2659906A1 (en) | 2012-05-01 | 2013-11-06 | Affiris AG | Compositions |
| US20140056901A1 (en) | 2012-08-21 | 2014-02-27 | The Institute For Molecular Medicine | Anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies |
| US20170368167A9 (en) * | 2012-08-21 | 2017-12-28 | The Institute For Molecular Medicine | Compositions and methods related to neurological disorders |
| WO2014165271A2 (en) | 2013-03-13 | 2014-10-09 | Neotope Biosciences Limited | Tau immunotherapy |
| CN105939722A (zh) | 2014-02-14 | 2016-09-14 | 伊皮埃里安股份有限公司 | Tau肽,抗Tau抗体,及其使用方法 |
| CA2952741A1 (en) | 2014-06-26 | 2015-12-30 | Janssen Vaccines & Prevention B.V. | Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau |
| NZ775762A (en) | 2015-06-05 | 2025-02-28 | Genentech Inc | Anti-tau antibodies and methods of use |
| CA2988436A1 (en) | 2015-07-13 | 2017-01-19 | Arvinas, Inc. | Alanine-based modulators of proteolysis and associated methods of use |
| EP4657376A3 (en) | 2015-08-14 | 2026-03-04 | Intuitive Surgical Operations, Inc. | Systems and methods of registration for image-guided surgery |
| MX2018013384A (es) | 2016-05-02 | 2019-02-28 | Prothena Biosciences Ltd | Anticuerpos que reconocen tau. |
| EP3551220B1 (en) | 2016-12-07 | 2025-01-29 | Genentech, Inc. | Anti-tau antibodies and methods of use |
| TW202333768A (zh) * | 2017-10-25 | 2023-09-01 | 美商健生醫藥公司 | Tau胜肽之組成物及其用途 |
| CN111587123A (zh) | 2017-11-09 | 2020-08-25 | 品通治疗有限公司 | 用于生成和使用人源化构象特异性磷酸化的τ抗体的方法和组合物 |
| SG11202108312PA (en) * | 2019-02-08 | 2021-08-30 | Ac Immune Sa | Method of safe administration of phosphorylated tau peptide vaccine |
| MX2021012994A (es) | 2019-04-24 | 2022-03-04 | Janssen Pharmaceuticals Inc | Administracion heterologa de vacunas tau. |
-
2018
- 2018-10-24 TW TW112117496A patent/TW202333768A/zh unknown
- 2018-10-24 CA CA3079423A patent/CA3079423A1/en active Pending
- 2018-10-24 CN CN202310829637.0A patent/CN117298259A/zh active Pending
- 2018-10-24 BR BR112020008168-0A patent/BR112020008168A2/pt active IP Right Grant
- 2018-10-24 WO PCT/US2018/057286 patent/WO2019084118A2/en not_active Ceased
- 2018-10-24 SG SG11202003556UA patent/SG11202003556UA/en unknown
- 2018-10-24 US US16/169,215 patent/US11124552B2/en active Active
- 2018-10-24 AR ARP180103100A patent/AR113792A1/es unknown
- 2018-10-24 CR CR20240219A patent/CR20240219A/es unknown
- 2018-10-24 IL IL302108A patent/IL302108A/en unknown
- 2018-10-24 EA EA202091012A patent/EA202091012A1/ru unknown
- 2018-10-24 JO JOP/2020/0103A patent/JOP20200103A1/ar unknown
- 2018-10-24 JP JP2020523284A patent/JP7550643B2/ja active Active
- 2018-10-24 MA MA050465A patent/MA50465A/fr unknown
- 2018-10-24 TW TW107137586A patent/TWI827557B/zh active
- 2018-10-24 US US16/757,621 patent/US11958889B2/en active Active
- 2018-10-24 KR KR1020247031724A patent/KR20240145065A/ko active Pending
- 2018-10-24 AU AU2018355325A patent/AU2018355325B2/en active Active
- 2018-10-24 CA CA3279357A patent/CA3279357A1/en active Pending
- 2018-10-24 MX MX2020004338A patent/MX2020004338A/es unknown
- 2018-10-24 IL IL273980A patent/IL273980B2/en unknown
- 2018-10-24 CN CN201880083892.2A patent/CN111787942B/zh active Active
- 2018-10-24 MY MYPI2020002058A patent/MY202233A/en unknown
- 2018-10-24 EP EP18804745.0A patent/EP3700556A2/en active Pending
- 2018-10-24 KR KR1020207014520A patent/KR102710762B1/ko active Active
-
2020
- 2020-04-15 PH PH12020550432A patent/PH12020550432A1/en unknown
- 2020-04-21 CL CL2020001070A patent/CL2020001070A1/es unknown
- 2020-04-23 SA SA520411820A patent/SA520411820B1/ar unknown
- 2020-05-18 CO CONC2020/0006073A patent/CO2020006073A2/es unknown
- 2020-05-22 EC ECSENADI202026986A patent/ECSP20026986A/es unknown
- 2020-07-02 DO DO2020000135A patent/DOP2020000135A/es unknown
- 2020-07-13 MX MX2024012209A patent/MX2024012209A/es unknown
-
2021
- 2021-01-27 CL CL2021000217A patent/CL2021000217A1/es unknown
- 2021-08-19 US US17/445,419 patent/US20210388044A1/en not_active Abandoned
-
2023
- 2023-02-09 JP JP2023018374A patent/JP7793562B2/ja active Active
-
2024
- 2024-11-11 AU AU2024259871A patent/AU2024259871A1/en active Pending
-
2025
- 2025-06-26 US US19/251,637 patent/US20250326806A1/en active Pending
- 2025-07-04 JP JP2025113783A patent/JP2025163031A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273980B1 (en) | Compositions of phosphorylated tau peptides and uses thereof | |
| JP2022520060A5 (cg-RX-API-DMAC7.html) | ||
| JP2021501147A5 (cg-RX-API-DMAC7.html) | ||
| JP4280309B2 (ja) | Dna免疫刺激配列活性の阻害剤 | |
| CN103747805B (zh) | 用于治疗、延缓和/或预防人类遗传性疾病如强直性肌营养不良症1型(dm1)的化合物 | |
| US20060189550A1 (en) | Immunostimulatory, Covalently lipidated oligonucleotides | |
| US20040038922A1 (en) | Vaccine composition | |
| US20250275920A1 (en) | Method of Safe Administration of Phosphorylated TAU Peptide Vaccine | |
| JP5165681B2 (ja) | タンパク質断片又はペプチドカクテルとして送達される抗原を用いたワクチン接種によるサブドミナントエピトープを含むt細胞レパートリーの拡大 | |
| US20230218730A1 (en) | Vaccine therapy for ran protein diseases | |
| WO1996013522A1 (en) | Complementarily bonded two- and three-dimensional supramolecular structures | |
| JP2022529529A5 (cg-RX-API-DMAC7.html) | ||
| JP2021517471A5 (cg-RX-API-DMAC7.html) | ||
| US20040009943A1 (en) | Pathogen vaccines and methods for using the same | |
| KR20220005033A (ko) | 타우 백신의 이종 투여 | |
| EP2300494A1 (en) | Anti-amyloid immunogenic compositions, methods and uses | |
| JP2024534786A5 (cg-RX-API-DMAC7.html) | ||
| WO2012141280A1 (ja) | Dnaワクチン | |
| EP1265632A2 (en) | Lipopeptide adjuvants | |
| EP1505942B1 (en) | Pathogen vaccines and methods for using the same | |
| EP1292333B1 (fr) | Composition adjuvante comprenant la proteine fha ou un fragment de la proteine fha sous forme libre | |
| JP2024532787A5 (cg-RX-API-DMAC7.html) | ||
| KR20230106325A (ko) | 핵산 복합체를 포함하는 퇴행성 뇌질환의 예방 또는 치료용 조성물 | |
| CA2204618A1 (fr) | Proteine g du virus respiratoire syncytial exprimee sur membrane bacterienne | |
| US20250144212A1 (en) | Liposomes containing phosphorylated tau peptides for inducing sustained immune responses |